Skip to content

Clinical trials

Observational Hemorrhagic Fever, Ebola trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Fever, Ebola Phase: Observational Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20162
20173
20181
20192
20201
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Not yet recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Tropical Medicine, Belgium3
National Institute of Allergy and Infectious Diseases (NIAID)3
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation2
Alliance for International Medical Action1
BioMérieux1
Institut National de la Santé Et de la Recherche Médicale, France1
London School of Hygiene and Tropical Medicine1
National Institute of Neurological Disorders and Stroke (NINDS)1
UL-PIRE Africa Center1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Fever, Ebola16
Hemorrhagic Fevers, Viral3
Bacterial Infections1
Chikungunya Fever1
Communicable Diseases, Emerging1
Dengue1
Lassa Fever1
Malaria1
Neurologic Manifestations1
Sepsis1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.